Clinical Scorecard: Impact of Maternal Thyroid Function During Pregnancy on Adolescent Brain Microstructure: Findings from the Controlled Antenatal Thyroid Screening Study III

At a Glance

Key Highlights

• Untreated SGTF is associated with altered white matter microstructure, specifically increased mean diffusivity in the inferior longitudinal fasciculus, indicating reduced axonal integrity.
• Levothyroxine treatment during pregnancy may reverse microstructural white matter alterations associated with SGTF.
• No significant macrostructural brain morphology differences were found, highlighting the importance of microstructural imaging techniques such as diffusion MRI and quantitative magnetization transfer imaging.

Guideline-Based Recommendations

Diagnosis

• Screen pregnant women for suboptimal thyroid function early in gestation (around 12 weeks) using thyrotropin (TSH) and free thyroxine (FT4) levels.

Management

• Administer levothyroxine supplementation to pregnant women diagnosed with SGTF to optimize thyroid hormone levels.
• Avoid overtreatment to prevent excessive FT4 levels during pregnancy.

Monitoring & Follow-up

• Monitor maternal thyroid hormone levels at 20 and 30 weeks' gestation to ensure optimal treatment.
• Follow-up neurodevelopmental assessments in offspring, including attention deficit hyperactivity disorder (ADHD) symptom evaluation.

Risks

• Untreated SGTF may lead to altered adolescent white matter microstructure potentially impacting cognitive functions.
• Overtreatment with levothyroxine may increase risk of hyperthyroidism-related adverse outcomes.

Patient & Prescribing Data

Pregnant women with suboptimal gestational thyroid function identified via antenatal screening

Levothyroxine treatment initiated from 12 weeks' gestation can normalize white matter microstructure alterations in offspring; however, overtreatment should be avoided.

Clinical Best Practices

• Implement early antenatal thyroid function screening to identify SGTF.
• Use levothyroxine supplementation judiciously to maintain maternal thyroid hormones within reference ranges.
• Utilize advanced neuroimaging modalities in research to monitor subtle brain microstructural changes related to maternal thyroid status.
• Consider neurodevelopmental follow-up of children born to mothers with thyroid dysfunction, focusing on cognitive and behavioral outcomes.

References

• Controlled Antenatal Thyroid Screening (CATS) Study
• Neurodevelopmental outcomes and maternal thyroid function
• Diffusion MRI and quantitative magnetization transfer imaging in brain microstructure